Upstream Bio
UPB
NASDAQ
IPO2024
about UPB
Upstream Bio is a biotechnology company focused on advancing gene therapy treatments for rare and genetic diseases through innovative research and development of cutting-edge therapies.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $19.00 | $20.01 | $12.65 | $1.5B | 8.84M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.63 | n/a | 1183.64 | -5539.39% | -4941.14% | 0% |